Patents by Inventor George S. Abrams

George S. Abrams has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 7867975
    Abstract: Endostatin compositions capable of inhibiting endothelial cell proliferation, inhibiting angiogenesis and causing tumor regression are described. Specifically, amino acid sequences of endostatin proteins and nucleic acid sequences coding for endostatin proteins are provided.
    Type: Grant
    Filed: December 15, 2008
    Date of Patent: January 11, 2011
    Assignee: The Children's Medical Center Corporation
    Inventors: Michael S. O'Reilly, M. Judah Folkman, George S. Abrams, legal representative
  • Publication number: 20090137518
    Abstract: Endostatin compositions capable of inhibiting endothelial cell proliferation, inhibiting angiogenesis and causing tumor regression are described. Specifically, amino acid sequences of endostatin proteins and nucleic acid sequences coding for endostatin proteins are provided.
    Type: Application
    Filed: December 15, 2008
    Publication date: May 28, 2009
    Applicant: The Children's Medical Center Corporation
    Inventors: Michael S. O'Reilly, M. Judah Folkman, George S. Abrams
  • Patent number: 7495089
    Abstract: Endostatin compositions capable of inhibiting endothelial cell proliferation, inhibiting angiogenesis and causing tumor regression are described. Specifically, amino acid sequences of endostatin proteins and nucleic acid sequences coding for endostatin proteins are provided.
    Type: Grant
    Filed: March 25, 2005
    Date of Patent: February 24, 2009
    Assignee: The Children's Medical Center Corporation
    Inventors: Michael S. O'Reilly, George S. Abrams, legal representative, M. Judah Folkman